As some states have passed laws decriminalizing the use of marijuana, USADA has received more questions from both athletes and the public about marijuana and anti-doping rules
A systematic review explored the role of GLP-1 drugs in managing headaches, particularly migraine and idiopathic intracranial hypertension (IIH)
However, patients receiving GLP-1-RAs had also been treated longer, which could have affected the likelihood of reducing the medication for IIH
The GLP-1s have multi-organ protective therapies with benefits spanning cardiovascular, kidney, liver, metabolic, and emerging neurologic domains as well
5-12 The most common patient-reported adverse effects (AEs) associated with GLP-1 RAs and dual GIP/GLP-1 RAs are gastrointestinal (GI) in nature and may include abdominal pain, constipation, diarrhea, nausea, and vomiting
The critical distinction from a treatment standpoint is availability